Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ELI LILLY AND COMPANY (LLY) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ELI LILLY AND COMPANY (LLY), most recent 12 months reported: revenue $79.67B, net income $26.71B, free cash flow $18.19B. Latest balance sheet on file: liquid cash $8.95B, total debt $54.91B, net cash -$45.96B. From SEC filings. More on ELI LILLY AND COMPANY: Revenue · Profitability · Cash flow · Debt · Dividends Others in Pharmaceutical Preparations: Johnson & Johnson · Merck & Co., Inc. · AbbVie Inc. · PFIZER INC · BRISTOL-MYERS SQUIBB COMPANY · ABBOTT LABORATORIES · Universe Pharmaceuticals INC · TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Stock screener

Watchlist